{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:56:17Z","timestamp":1772160977112,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,3,21]],"date-time":"2015-03-21T00:00:00Z","timestamp":1426896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00296-015-3256-7","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T08:16:37Z","timestamp":1426839397000},"page":"1575-1580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis"],"prefix":"10.1007","volume":"35","author":[{"given":"Muhammet","family":"Cinar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Ilknur","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman Serdar","family":"Koca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Pay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Dinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,21]]},"reference":[{"key":"3256_CR1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.berh.2007.02.010","volume":"21","author":"J Zochling","year":"2007","unstructured":"Zochling J, Braun J (2007) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 21:699\u2013712","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3256_CR2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","volume":"70","author":"D Heijde Van Der","year":"2011","unstructured":"Van Der Heijde D, Sieper J, Maksymowych WP et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905\u2013908","journal-title":"Ann Rheum Dis"},{"key":"3256_CR3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.berh.2006.03.011","volume":"20","author":"J Zochling","year":"2006","unstructured":"Zochling J, Braun J, Van Der Heijde D (2006) Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol 20:521\u2013537","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3256_CR4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","volume":"44","author":"A Spoorenberg","year":"2005","unstructured":"Spoorenberg A, Van Tubergen A, Landewe R et al (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatol (Oxf) 44:789\u2013795","journal-title":"Rheumatol (Oxf)"},{"key":"3256_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.rdc.2009.10.017","volume":"35","author":"T Pincus","year":"2009","unstructured":"Pincus T, Askanase AD, Swearingen CJ (2009) A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am 35:819\u2013827","journal-title":"Rheum Dis Clin North Am"},{"key":"3256_CR6","first-page":"966","volume":"26","author":"J Ruof","year":"1999","unstructured":"Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966\u2013970","journal-title":"J Rheumatol"},{"key":"3256_CR7","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"3256_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.2008.097774","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1\u201344","journal-title":"Ann Rheum Dis"},{"key":"3256_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landewe R, Sieper J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18\u201324","journal-title":"Ann Rheum Dis"},{"key":"3256_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/BOR.0b013e3283470f23","volume":"23","author":"P Machado","year":"2011","unstructured":"Machado P, Van Der Heijde D (2011) How to measure disease activity in axial spondyloarthritis? Curr Opin Rheumatol 23:339\u2013345","journal-title":"Curr Opin Rheumatol"},{"key":"3256_CR11","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde Van Der","year":"2009","unstructured":"Van Der Heijde D, Lie E, Kvien TK et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818","journal-title":"Ann Rheum Dis"},{"key":"3256_CR12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1756-185X.2010.01537.x","volume":"13","author":"K Nas","year":"2010","unstructured":"Nas K, Yildirim K, Cevik R et al (2010) Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis. Int J Rheum Dis 13:240\u2013245","journal-title":"Int J Rheum Dis"},{"key":"3256_CR13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","volume":"69","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, Sorensen IJ, Hermann KG et al (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065\u20131071","journal-title":"Ann Rheum Dis"},{"key":"3256_CR14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/anr.1790020406","volume":"2","author":"LF Callahan","year":"1989","unstructured":"Callahan LF, Smith WJ, Pincus T (1989) Self-report questionnaires in five rheumatic diseases: comparisons of health status constructs and associations with formal education level. Arthritis Care Res 2:122\u2013131","journal-title":"Arthritis Care Res"},{"key":"3256_CR15","first-page":"30","volume":"70","author":"T Pincus","year":"2012","unstructured":"Pincus T, Yazici Y, Castrejon I (2012) Pragmatic and scientific advantages of MDHAQ\/RAPID3 completion by all patients at all visits in routine clinical care. Bull NYU Hosp Jt Dis 70:30\u201336","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"3256_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0b013e3182936b98","volume":"19","author":"I Castrejon","year":"2013","unstructured":"Castrejon I, Bergman MJ, Pincus T (2013) MDHAQ\/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol 19:169\u2013174","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 10","key":"3256_CR17","first-page":"1527A","volume":"65","author":"A Danve","year":"2013","unstructured":"Danve A, Vakil-Gilani K, Reddy A, Sheffield A, Dinno A, Deodhar A (2013) Routine Assessment of Patient Index Data 3 Scores Correlate Well With Bath Ankylosing Spondylitis Disease Activity Index in the Assessment of Disease Activity and Monitoring Progression of Ankylosing Spondylitis [abstract]. Arthritis Rheum 65(Suppl 10):1527A","journal-title":"Arthritis Rheum"},{"key":"3256_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden Van Der","year":"1984","unstructured":"Van Der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"3256_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acr.20066","volume":"62","author":"T Pincus","year":"2010","unstructured":"Pincus T, Cj Swearingen, Mj Bergman (2010) RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res (Hoboken) 62:181\u2013189","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3256_CR20","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"3256_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado P, Landewe R, Lie E et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47\u201353","journal-title":"Ann Rheum Dis"},{"key":"3256_CR22","first-page":"104","volume":"69","author":"I Castrej\u00f3n","year":"2011","unstructured":"Castrej\u00f3n I, Pincus T (2011) Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes\u2014consequences for clinical care. Bull NYU Hosp Jt Dis 69:104\u2013110","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"3256_CR23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2009.123976","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Knevel R, Aletaha D et al (2010) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 69:638\u2013643","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"3256_CR24","first-page":"33","volume":"71","author":"T Pincus","year":"2013","unstructured":"Pincus T, Castrej\u00f3n I (2013) Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target. Bull Hosp Jt Dis 71(Suppl 1):33\u201340","journal-title":"Bull Hosp Jt Dis"},{"key":"3256_CR25","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/rheumatology\/ket230","volume":"52","author":"I Castrej\u00f3n","year":"2013","unstructured":"Castrej\u00f3n I, Pincus T, Soubrier M, Al Et (2013) GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate. Rheumatol (Oxf) 52:1890\u20131897","journal-title":"Rheumatol (Oxf)"},{"key":"3256_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"Smolen Js","year":"2014","unstructured":"Js Smolen, Braun J, Dougados M, Al Et (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73:6\u201316","journal-title":"Ann Rheum Dis"},{"key":"3256_CR27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/rheumatology\/kem065","volume":"46","author":"N Smith","year":"2007","unstructured":"Smith N, Gadsby K, Butt S, Deighton C (2007) The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis. Rheumat (Oxf) 46:1044\u20131045","journal-title":"Rheumat (Oxf)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3256-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3256-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3256-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T01:42:35Z","timestamp":1598838155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3256-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,21]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3256"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3256-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,21]]}}}